Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 229

    1.

    Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.

    Dalle S, Fontés G, Lajoix AD, LeBrigand L, Gross R, Ribes G, Dufour M, Barry L, LeNguyen D, Bataille D.

    Diabetes. 2002 Feb;51(2):406-12.PMID: 11812748 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Miniglucagon: a local regulator of islet physiology.

    Dalle S, Blache P, Le-Nguyen D, Le Brigand L, Bataille D.

    Ann N Y Acad Sci. 1998 Dec 11;865:132-40.PMID: 9928005 [PubMed - indexed for MEDLINE]Related articles

    3.

    Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway.

    Dalle S, Smith P, Blache P, Le-Nguyen D, Le Brigand L, Bergeron F, Ashcroft FM, Bataille D.

    J Biol Chem. 1999 Apr 16;274(16):10869-76.PMID: 10196164 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.

    Wang F, Adrian TE, Westermark GT, Ding X, Gasslander T, Permert J.

    Am J Physiol. 1999 Jan;276(1 Pt 1):E19-24.PMID: 9886946 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.

    Hui H, Yu R, Bousquet C, Perfetti R.

    Endocrinology. 2002 Sep;143(9):3529-39. Erratum in: Endocrinology 2002 Nov;143(11):4349. PMID: 12193567 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release.

    Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB.

    Diabetes. 2005 Jun;54(6):1808-15.PMID: 15919803 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells.

    Moens K, Berger V, Ahn JM, Van Schravendijk C, Hruby VJ, Pipeleers D, Schuit F.

    Diabetes. 2002 Mar;51(3):669-75.PMID: 11872665 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion.

    Buchanan CM, Phillips AR, Cooper GJ.

    Biochem J. 2001 Dec 1;360(Pt 2):431-9.PMID: 11716772 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pancreastatin--a mediator in the islet-acinar axis?

    von Schönfeld J, Müller MK, Rünzi M, Geling M, Neisius I, Kleimann J, Goebell H.

    Metabolism. 1993 May;42(5):552-5.PMID: 8492708 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

    Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA.

    Diabetes. 2003 Mar;52(3):741-50.PMID: 12606516 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The glucagon-miniglucagon interplay: a new level in the metabolic regulation.

    Bataille D, Fontés G, Costes S, Longuet C, Dalle S.

    Ann N Y Acad Sci. 2006 Jul;1070:161-6. Review.PMID: 16888159 [PubMed - indexed for MEDLINE]Related articles

    13.

    Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.

    Miki T, Minami K, Shinozaki H, Matsumura K, Saraya A, Ikeda H, Yamada Y, Holst JJ, Seino S.

    Diabetes. 2005 Apr;54(4):1056-63.PMID: 15793244 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas.

    Silvestre RA, Rodríguez-Gallardo J, Marco J.

    Diabetes. 1996 Sep;45(9):1157-60.PMID: 8772715 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas.

    Ito K, Hirose H, Maruyama H, Fukamachi S, Tashiro Y, Saruta T.

    Diabetologia. 1995 Nov;38(11):1276-84.PMID: 8582536 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release.

    Qader SS, Lundquist I, Ekelund M, Håkanson R, Salehi A.

    Regul Pept. 2005 May 15;128(1):51-6.PMID: 15721487 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.

    Salehi A, Dornonville de la Cour C, Håkanson R, Lundquist I.

    Regul Pept. 2004 May 15;118(3):143-50.PMID: 15003830 [PubMed - indexed for MEDLINE]Related articles

    19.

    Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.

    Høy M, Olsen HL, Andersen HS, Bokvist K, Buschard K, Hansen J, Jacobsen P, Petersen JS, Rorsman P, Gromada J.

    Eur J Pharmacol. 2003 Apr 11;466(1-2):213-21.PMID: 12679159 [PubMed - indexed for MEDLINE]Related articles

    20.

    The islet-acinar axis of the pancreas: is there a role for glucagon or a glucagon-like peptide?

    von Schönfeld J, Müller MK.

    Experientia. 1994 May 15;50(5):442-6.PMID: 7515009 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data